Roth Capital Initiates Coverage On Nautilus Biotechnology with Buy Rating, Announces Price Target of $3.5
Top 3 Health Care Stocks That May Rocket Higher In July - Anbio Biotechnology (NASDAQ:NNNN), Evommune (NY